New York Times.
Britain Grants License to Make Human Embryos for Stem Cells
By HEATHER TIMMONS
Published: August 12, 2004
ONDON, Aug. 11 - British regulators on Wednesday issued the country's first license to use cloning techniques to generate a human embryo to produce stem cells that might be used for the treatment of disease.
The one-year license was granted to researchers at the Newcastle Center for Life, in northern England, who hope to develop tissues that will treat diabetes, Alzheimer's and other diseases
The license allows them to insert cell nuclei taken from a patient's skin into human eggs from which the nuclei have been removed, a process known as therapeutic cloning. Stem cells created as the embryo grows can be converted to cells of the tissue type the donor needs repaired.
Stem cell research is controversial because the embryo must be destroyed to harvest the cells. A 2001 Bush administration decision limits researchers using federal money to existing stem cell lines. In July, the French Parliament banned human cloning for any purpose.
Three years ago, Britain became the first country to allow therapeutic cloning; Newcastle has won the country's first license. In February, South Korean scientists became the first to create a human embryo for therapeutic research.
Scientists involved in the Newcastle project say they hope to find some cures rapidly through therapeutic cloning.
"In 5 or 10 years, we'd like to be in a position where a patient with Parkinson's or diabetes could come to us, and we could take a skin cell from them and reprogram it," said Alison Murdoch of Newcastle's fertility center. Reinserting the altered cell could cure the disease
http://www.nytimes.com/2004/08/12/science/12clone.html